Phase 2 ExpectationsLowered Phase 2 sales volume expectations, now only expecting $37kt of SC sold in the year vs 137kt spodumene prior.
Price ExpectationsLowering 2025 price recovery expectations due to oversupply, minimal industry discipline, and stagnant inventory levels.
Sales VolumeSales volume of ~53kt was flat but below the ~66kt estimate with SGML guiding to 60kt in Q3, also below the ~66kt estimate.